Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

A malaria vaccine for control: more progress.

Breman JG, Plowe CV.

J Infect Dis. 2009 Aug 1;200(3):317-20. doi: 10.1086/600121. No abstract available.

2.

The hope but challenge for developing a vaccine that might control malaria.

Good MF.

Eur J Immunol. 2009 Apr;39(4):939-43. doi: 10.1002/eji.200939390.

3.

Malaria vaccine development: progress and challenges.

Reed ZH, Friede M, Kieny MP.

Curr Mol Med. 2006 Mar;6(2):231-45. Review.

PMID:
16515513
4.

Malaria vaccine progress.

[No authors listed]

Bull World Health Organ. 1999;77(4):361-2. No abstract available.

5.

Malaria vaccines: into a mirror, darkly?

Plebanski M, Locke E, Kazura JW, Coppel RL.

Trends Parasitol. 2008 Dec;24(12):532-6. doi: 10.1016/j.pt.2008.09.006. Epub 2008 Oct 18.

PMID:
18938108
6.

Simulation of the cost-effectiveness of malaria vaccines.

Tediosi F, Maire N, Penny M, Studer A, Smith TA.

Malar J. 2009 Jun 8;8:127. doi: 10.1186/1475-2875-8-127.

7.

Malaria vaccines: immunity, models and monoclonal antibodies.

Hviid L, Barfod L.

Trends Parasitol. 2008 Sep;24(9):392-5. doi: 10.1016/j.pt.2008.05.007. Epub 2008 Jul 31.

PMID:
18675589
8.

The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

Plowe CV, Alonso P, Hoffman SL.

J Infect Dis. 2009 Dec 1;200(11):1646-9. doi: 10.1086/646613. No abstract available.

9.

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.

Lusingu JP, Gesase S, Msham S, Francis F, Lemnge M, Seth M, Sembuche S, Rutta A, Minja D, Segeja MD, Bosomprah S, Cousens S, Noor R, Chilengi R, Druilhe P.

Malar J. 2009 Jul 17;8:163. doi: 10.1186/1475-2875-8-163.

10.

Malaria--still waiting for a vaccine.

Molyneux ME.

Trop Doct. 1994 Jul;24(3):97-8. No abstract available.

PMID:
8091538
11.

Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.

Sacarlal J, Aide P, Aponte JJ, Renom M, Leach A, Mandomando I, Lievens M, Bassat Q, Lafuente S, Macete E, Vekemans J, Guinovart C, Sigaúque B, Sillman M, Milman J, Dubois MC, Demoitié MA, Thonnard J, Menéndez C, Ballou WR, Cohen J, Alonso PL.

J Infect Dis. 2009 Aug 1;200(3):329-36. doi: 10.1086/600119.

12.

Malaria--a global crisis.

Brown GV.

Dev Biol (Basel). 2002;110:37-45. Review.

PMID:
12477305
13.

Worms can alter T cell responses and induce regulatory T cells to experimental malaria vaccines.

Druilhe P, Sauzet JP, Sylla K, Roussilhon C.

Vaccine. 2006 Jun 5;24(23):4902-4. Epub 2006 Mar 24. No abstract available.

PMID:
16616801
14.

Quest for malaria vaccine revs up, but much work remains.

Walgate R.

Bull World Health Organ. 2001;79(10):1002-4. Epub 2001 Nov 1. No abstract available.

15.

Malaria. Vaccine comes another step closer.

Enserink M.

Science. 2008 Dec 12;322(5908):1622-3. doi: 10.1126/science.322.5908.1622b. No abstract available.

PMID:
19074320
16.

A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.

Chowdhury DR, Angov E, Kariuki T, Kumar N.

PLoS One. 2009 Jul 22;4(7):e6352. doi: 10.1371/journal.pone.0006352.

17.

Malaria vaccine trial endpoints - bridging the gaps between trial design, public health and the next generation of vaccines.

O'Meara WP, Lang T.

Parasite Immunol. 2009 Sep;31(9):574-81. doi: 10.1111/j.1365-3024.2009.01144.x. Review.

18.

Malaria--still unconquered.

Soman R.

J Assoc Physicians India. 2006 Nov;54:843-4. No abstract available.

PMID:
17249249
19.

Measuring malaria.

Carter R, Mendis K.

Am J Trop Med Hyg. 2006 Feb;74(2):187-8. No abstract available.

20.

Status of malaria vaccine R&D in 2007. Malaria Vaccines for the World 2007, September 17-19th, 2007, London, UK.

Doolan DL, Stewart VA.

Expert Rev Vaccines. 2007 Dec;6(6):903-5. doi: 10.1586/14760584.6.6.903. No abstract available.

PMID:
18377353
Items per page

Supplemental Content

Write to the Help Desk